Anupam Rasayan India working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
444.96×444.96×756.83×590.16×465.53×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
130.63×130.63×166.77×123.04×79.20×
209.90×209.90×299.36×219.14×167.35×
365.69×365.69×624.24×494.06×377.38×
2.28×2.13×1.88×1.62×1.23×
0.36×0.36×0.29×0.35×0.48×
1.50×1.50×−0.19×0.35×1.35×
0.64×0.64×−0.08×0.16×0.68×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ANURAS₹1,182.00

Anupam Rasayan India Ltd.

· Chemicals
₹ CrorePeersAETHERPIINDATULSHKBAYERCROPSWANCORPCAMLINFINECLEANMcap ₹13,457 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)465.53590.16756.83444.96444.96
Receivable Days (DSO)79.20123.04166.77130.63130.63
Payable Days (DPO)167.35219.14299.36209.90209.90
Cash Conversion Cycle (days)377.38494.06624.24365.69365.69
Working Capital Turnover1.231.621.882.132.28
Asset Turnover0.480.350.290.360.36
Cash Conversion (CFO/Net Income)1.350.35-0.191.501.50
CFO/EBITDA0.680.16-0.080.640.64
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.